Advanced diffusion-weighted imaging models better characterize white matter neurodegeneration and clinical outcomes

Loredana Storelli1, Elisabetta Pagani1, Alessandro Meani1

  • 1Neuroimaging Research Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Journal of Neurology
|April 10, 2022
PubMed
Abstract

Insights

Advanced diffusion imaging techniques, specifically fiber-bundle cross-section (FCS) and intra-cellular volume (vic), can detect white matter atrophy in multiple sclerosis (MS) and predict clinical disability. These novel measures offer greater specificity than traditional methods.

Area of Science:

  • Neuroimaging
  • Neurology
  • Medical Physics

Background:

  • White matter (WM) atrophy is a key feature of multiple sclerosis (MS), but current analysis methods lack microstructural specificity.
  • Advanced diffusion-weighted imaging (DWI) techniques offer potential for more precise WM atrophy assessment in MS.

Purpose of the Study:

  • To evaluate advanced DWI techniques, neurite orientation dispersion and density imaging (NODDI)-derived intra-cellular volume (vic) and voxel-wise fiber-bundle cross-section (FCS) atrophy, as measures of baseline and longitudinal WM atrophy in MS.
  • To compare the ability of these advanced DWI measures to explain MS clinical disability, including cognitive impairment, against traditional volumetric and diffusion tensor (DT)-derived measures.

Main Methods:

  • Acquired 3DT1-weighted and DWI sequences from 86 MS patients and 55 healthy controls (HC) at baseline and one-year follow-up.
  • Computed intra-cellular volume (vic) maps using the NODDI model and estimated voxel-wise fiber-bundle cross-section (FCS) atrophy.
  • Obtained fractional anisotropy and mean diffusivity maps for comparison with vic and FCS measures.

Main Results:

  • FCS demonstrated significant WM atrophy in relapsing-remitting MS (RRMS) and progressive MS compared to HC and RRMS, respectively, with specific tract localization (p < 0.05).
  • Global baseline FCS and vic were significant predictors of clinical disability (R-sq = 0.33) and cognitive scores (R-sq = 0.29) in linear regression models.

Conclusions:

  • Voxel-based FCS provides anatomically specific detection of WM tract atrophy in MS phenotypes, outperforming volumetric and DT-derived measures.
  • Baseline FCS and vic measurements in WM are superior predictors of clinical disability and cognitive impairment in MS patients.

Related Concept Videos